RDIF sees opportunities for the production of the drug "Aviewer" in Cuba
The Russian direct investment Fund (RDIF) sees possibilities for the production of Russian medicines in the fashion industry, "Aviewer" Cuba, go discussions, told reporters the head of RDIF Kirill Dmitriev.
"Cuba is very strong pharmaceuticals. We are in contact with Cuban colleagues, including our drug "Avidavit". We would love to have this preparation was done in Cuba," - said Dmitriev.
"Aviewer", in which participated the FUND, may 29, received a registration certificate of Ministry of health of the Russian Federation and became the world's first drug against the coronavirus that contains active substance favipiravir, and on 3 June was included in the list of methodological recommendations for the prevention, diagnosis and treatment of new coronavirus infection.
Recent data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.